517 related articles for article (PubMed ID: 19532026)
21. Serum angiopoietin-2 and CRP levels during COPD exacerbations.
Nikolakopoulou S; Hillas G; Perrea D; Tentolouris N; Loukides S; Kostikas K; Simoes D; Georgakopoulou E; Vogiatzakis E; Veldekis D; Bakakos P
COPD; 2014 Feb; 11(1):46-51. PubMed ID: 24102428
[TBL] [Abstract][Full Text] [Related]
22. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD.
Tkacova R; Kluchova Z; Joppa P; Petrasova D; Molcanyiova A
Respir Med; 2007 Aug; 101(8):1670-6. PubMed ID: 17449234
[TBL] [Abstract][Full Text] [Related]
23. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease.
Kirdar S; Serter M; Ceylan E; Sener AG; Kavak T; Karadağ F
Scand J Clin Lab Invest; 2009; 69(2):219-24. PubMed ID: 18946779
[TBL] [Abstract][Full Text] [Related]
24. C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.
Gallego M; Pomares X; Capilla S; Marcos MA; Suárez D; Monsó E; Montón C
Int J Chron Obstruct Pulmon Dis; 2016; 11():2633-2640. PubMed ID: 27799762
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease.
Briggs A; Spencer M; Wang H; Mannino D; Sin DD
Arch Intern Med; 2008 Jan; 168(1):71-9. PubMed ID: 18195198
[TBL] [Abstract][Full Text] [Related]
26. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease.
Bozinovski S; Hutchinson A; Thompson M; Macgregor L; Black J; Giannakis E; Karlsson AS; Silvestrini R; Smallwood D; Vlahos R; Irving LB; Anderson GP
Am J Respir Crit Care Med; 2008 Feb; 177(3):269-78. PubMed ID: 18006888
[TBL] [Abstract][Full Text] [Related]
27. Biomarkers in chronic obstructive pulmonary disease.
Rosenberg SR; Kalhan R
Transl Res; 2012 Apr; 159(4):228-37. PubMed ID: 22424427
[TBL] [Abstract][Full Text] [Related]
28. A new measure of acute physiological derangement for patients with exacerbations of obstructive airways disease: the COPD and Asthma Physiology Score.
Wildman MJ; Harrison DA; Welch CA; Sanderson C
Respir Med; 2007 Sep; 101(9):1994-2002. PubMed ID: 17616454
[TBL] [Abstract][Full Text] [Related]
29. Serum magnesium levels and acute exacerbation of chronic obstructive pulmonary disease: a retrospective study.
Aziz HS; Blamoun AI; Shubair MK; Ismail MM; DeBari VA; Khan MA
Ann Clin Lab Sci; 2005; 35(4):423-7. PubMed ID: 16254259
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and outcome of severe chronic obstructive pulmonary disease exacerbations caused by multidrug-resistant bacteria.
Nseir S; Ader F
Curr Opin Pulm Med; 2008 Mar; 14(2):95-100. PubMed ID: 18303416
[TBL] [Abstract][Full Text] [Related]
31. Risk assessment in asthma and COPD: a potential role for biomarkers?
Taylor DR
Thorax; 2009 Mar; 64(3):261-4. PubMed ID: 19252021
[TBL] [Abstract][Full Text] [Related]
32. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
33. Identification of distinct plasma biomarker signatures in patients with rapid and slow declining forms of COPD.
Devanarayan V; Scholand MB; Hoidal J; Leppert MF; Crackower MA; O'Neill GP; Gervais FG
COPD; 2010 Feb; 7(1):51-8. PubMed ID: 20214463
[TBL] [Abstract][Full Text] [Related]
34. Biomarkers in the management of COPD.
Lacoma A; Prat C; Andreo F; Domínguez J
Eur Respir Rev; 2009 Jun; 18(112):96-104. PubMed ID: 20956129
[TBL] [Abstract][Full Text] [Related]
35. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
[TBL] [Abstract][Full Text] [Related]
36. Elevation of cardiac troponins in exacerbation of chronic obstructive pulmonary disease.
Harvey MG; Hancox RJ
Emerg Med Australas; 2004 Jun; 16(3):212-5. PubMed ID: 15228464
[TBL] [Abstract][Full Text] [Related]
37. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
[TBL] [Abstract][Full Text] [Related]
38. Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease.
Wang RT; Li JY; Cao ZG; Li Y
Respirology; 2013 Nov; 18(8):1244-8. PubMed ID: 23786593
[TBL] [Abstract][Full Text] [Related]
39. Prophylactic vaccinations in chronic obstructive pulmonary disease: current status.
Varkey JB; Varkey AB; Varkey B
Curr Opin Pulm Med; 2009 Mar; 15(2):90-9. PubMed ID: 19532022
[TBL] [Abstract][Full Text] [Related]
40. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
